Apollon Formularies - Notice of AGM
Announcement provided by
Apollon Formularies plc · APOL02/12/2022 07:00
2 December 2022
Apollon Formularies Plc
Notice of AGM
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), announces that notice of its Annual General Meeting ('AGM') has been posted to shareholders, and will shortly be available at the Company website on https://www.apollon.org.uk/. The AGM will be held on 30 December 2022 at 10am, at 48 Warwick Street,
The directors of the Company accept responsibility for the contents of this announcement.
ENDS
For additional information, please visit www.apollon.org.uk or contact:
Apollon Formularies
Tel: +44 771 198 0221
Stene Jacobs stene@apollon.org.uk
Peterhouse Capital Limited (Corporate Adviser)
Tel: +44 207 220 9795
Guy Miller gm@peterhousecapital.com
Blytheweigh (Financial PR/IR-London)
Tel: +44 207 138 3204
Tim Blythe/Megan Ray apollon@blytheray.com
About Apollon and Apollon Jamaica
Apollon Formularies plc is an international medical cannabis and medicinal mushroom pharmaceutical company headquartered in the United Kingdom. Apollon Formularies Jamaica Limited is a pharmaceutical company incorporated and operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate (R&D), perform research and development, process, and sell medical cannabis therapeutic products that include legal medical cannabis to treat various illnesses under medical supervision.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.